Cinctive Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Cinctive Capital Management's ALNY Position: Q3 2026 in Review
Cinctive Capital Management sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2026, closing a stake of 3,305 shares — an estimated $995K sold.
Cinctive Capital Management first reported a position in ALNY in Q4 2020 and held it in 8 quarters. The position peaked at $7.46M in Q2 2025. 720 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Cinctive Capital Management reported no remaining Alnylam Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Cinctive Capital Management sold 3,305 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $995K.
- Cinctive Capital Management first reported a position in Alnylam Pharmaceuticals in Q4 2020 and held it in 8 quarters.
- Cinctive Capital Management's Alnylam Pharmaceuticals position peaked at $7.46M in Q2 2025.
- 720 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Cinctive Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.